Envista Holdings Corporation (NYSE:NVST - Get Free Report) has received a consensus recommendation of "Hold" from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $21.0769.
A number of analysts recently weighed in on the stock. UBS Group increased their price objective on shares of Envista from $18.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 29th. Piper Sandler raised their target price on shares of Envista from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Wall Street Zen downgraded shares of Envista from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 30th. Zacks Research downgraded shares of Envista from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 15th. Finally, Morgan Stanley lifted their price objective on shares of Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a report on Friday, August 1st.
Read Our Latest Report on NVST
Hedge Funds Weigh In On Envista
Institutional investors and hedge funds have recently bought and sold shares of the business. Farther Finance Advisors LLC boosted its position in Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company's stock worth $27,000 after acquiring an additional 1,026 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after acquiring an additional 949 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. SJS Investment Consulting Inc. lifted its holdings in shares of Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company's stock worth $49,000 after acquiring an additional 2,382 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Envista by 34.3% during the 3rd quarter. GAMMA Investing LLC now owns 2,498 shares of the company's stock worth $51,000 after buying an additional 638 shares during the period.
Envista Stock Up 0.9%
Shares of NYSE:NVST opened at $20.40 on Friday. The company has a current ratio of 2.44, a quick ratio of 2.08 and a debt-to-equity ratio of 0.46. Envista has a 12 month low of $14.22 and a 12 month high of $23.00. The company has a 50-day moving average price of $20.59 and a 200 day moving average price of $19.22. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 63.75, a PEG ratio of 1.09 and a beta of 1.01.
Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Envista had a net margin of 2.11% and a return on equity of 4.84%. The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same period in the prior year, the company posted $0.11 EPS. The firm's revenue for the quarter was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. As a group, equities research analysts predict that Envista will post 1 earnings per share for the current year.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.